Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 423
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04355520 | A Study of TQ-B3525 Tablets Combined With Fulvestrant Injection in Subjects With HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer | ||
| NCT05849727 | A Clinical Study of TQH3821 Tablets in the Treatment of Treated Rheumatoid Arthritis | ||
| NCT06711991 | A Clinical Trial of TQC3927 Powder for Inhalation in Chronic Obstructive Pulmonary Disease | ||
| NCT02072044 | Phase II Study of Anlotinib in Patients With Advanced Renal Cell Carcinoma That Have Failed Or Are Intolerant To TKIs Therapy | ||
| NCT04623333 | A Study of TQB2450 Injection in Subjects With PD-L1 Positive Recurrent or Metastatic Cervical Cancer | ||
| NCT04326348 | A Study of TQ05105 Tablets in Subjects With Hemophagocytic Lymphohistiocytosis（HLH） | ||
| NCT07187960 | Evaluation of the Efficacy and Safety of TQB2825 Injection Compared to Immunotherapy in the Treatment of Recurrent/Refractory Follicular Lymphoma | ||
| NCT02586350 | Study of Anlotinib in Patients With Medullary Thyroid Carcinoma(ALTER01031) | ||
| NCT06408285 | A Study of TQC3927 Powder for Inhalation in Healthy Adult Subjects | ||
| NCT06851442 | Clinical Trial of Evaluating TQB3912 Tablets Combined With Fulvestrant Injection±TQB3616 Capsules for Locally Advanced or Metastatic Hormone Receptor(HR)-Positive and Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer | ||
| NCT06798207 | A Clinical Trial of TQB2102 for Injection in Gynecological Tumors With Recurrent/Metastatic Advanced | ||
| NCT04619537 | A Trial of Anlotinib Combined With Docetaxel in Patients With Wild-type Advanced Non-squamous Non Small Cell Lung Cancer | ||
| NCT05975645 | A Clinical Study of TQB2618 Injection Combined With Penpulimab Injection and Anlotinib Hydrochloride Capsules for First-line Treatment of Advanced Hepatocellular Carcinoma (HCC). | ||
| NCT06873854 | A Study of LM-108 in Combination With Toripalimab in Subjects With Advanced Solid Tumours | ||
| NCT06598956 | To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Renal Impairment Subjects | ||
| NCT04202653 | Combination of ETV, TQ-A3334 and TQ-B2450 for CHB (Neptune Study) | ||
| NCT04675697 | Anlotinib Plus Platinum-etoposide in First-line of Extensive-stage Small-cell Lung Cancer | ||
| NCT06036927 | A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal Polyps | ||
| NCT04275050 | A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3303 Tablets | ||
| NCT06730620 | Bioequivalence Study of Methacholine Chloride | ||
| NCT04373395 | Decitabine+Cladribine+Cytarabine+Granulocyte Colony-stimulating Factor (D-CLAG) for Relapsed or Refractory Acute Myeloid Leukemia (AML) | ||
| NCT05344729 | Clinical Trial for Effect of TQB3616 Capsule on Pharmacokinetics in Healthy Adult Subjects | ||
| NCT05913089 | A Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung Cancer | ||
| NCT06767813 | Clinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in the First-line Treatment of Metastatic Pancreatic Neoplasms | ||
| NCT06439381 | Long-term Safety and Efficacy of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps | ||
| NCT03800706 | A Phase II Study to Evaluate the Safety and Efficacy of TQB2450 Injection in Relapsed or Refractory Classical Hodgkin's Lymphoma | ||
| NCT06024915 | A Study to Evaluate Drug-Drug Interaction of TQ05105 Tablets | ||
| NCT01886053 | A Phase II Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia | ||
| NCT06621095 | Anlotinib Plus Benmelstobart and AG in First-line Treatment of Advanced Metastatic Pancreatic Cancer (ALTER-PA-001) | ||
| NCT06768619 | Bioequivalence Study of Eltrombopag Olamine Tablets in Healthy Subjects in the Fed State | ||
| NCT01806376 | A Phase I Study of Subutinib Maleate Capsules on Toleration and Pharmacokinetics | ||
| NCT05815862 | Clinical Study of AL2846 Capsules in the Treatment of Advanced Lung Tumor and Advanced Ovarian Cancer | ||
| NCT04002622 | Study of TQB2450 Injection in Subjects With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma | ||
| NCT06859931 | Clinical Trial of TQB3702 Tablets in Subjects With Systemic Lupus Erythematosus (SLE) | ||
| NCT04073550 | Study of Anlotinib Hydrochloride Capsule in Subjects With Small Cell Lung Cancer | ||
| NCT06297642 | TQB2928 Injection Combined With Penpulimab in Treatment of Advanced Malignant Tumors. | ||
| NCT03589950 | Anlotinib Plus Chemotherapy for Patients With Advanced Non-small Cell Lung Cancer | ||
| NCT07003074 | A Clinical Study of TQB2102 Versus Docetaxel Plus Trastuzumab and Pertuzumab in the Treatment of HER2 Positive Recurrent or Metastatic Breast Cancer | ||
| NCT04955834 | A Clinical Study of Insulin Degludec Injection in Subjects With Type 2 Diabetes | ||
| NCT06542614 | Treatment of Moderate to Severe Plaque Psoriasis | ||
| NCT05780567 | Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer | ||
| NCT02752516 | A Phase I Additional Study of Anlotinib on Tolerance and Pharmacokinetics | ||
| NCT07266116 | Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain Amyloidosis Patients | ||
| NCT03855384 | Study of TQB2450 in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck（R/M SCCHN） | ||
| NCT05121363 | A Clinical Trial to Evaluate TQB2858 Injection Combined With Anlotinib Hydrochloride Capsule in the Treatment of Recurrent or Metastatic Advanced Endometrial Carcinoma | ||
| NCT05870436 | A Study on the Diagnostic Value of the Methacholine Choline Provocation Test in the Asthmatic Population | ||
| NCT06522945 | To Evaluate the Pharmacokinetics and Safety of TQD3524 for Injection in Renal Impairment Subjects | ||
| NCT05068206 | A Clinical Study to Compare the Efficacy and Safety of AK105 Plus Anlotinib and Capecitabine/Oxaliplatin (CapeOx) , Anlotinib Plus CapeOx, Bevacizumab Plus CapeOx | ||
| NCT06448273 | A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacokinetic of TQB3702 Tablets in Healthy Adult Subjects | ||
| NCT04291248 | A Study of Anlotinib Combined With AK105 Injection in Subjects With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Advanced Solid Tumor |
